ShouTi Company

ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
Industry: Early Drug Development
Headquarters: South San Francisco, California, United States
Founded Date: 2016-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 18
Total Funding: 207000000
Last Funding Date: 2021-10-20
Last Funding Type: Series B

Visit Website
Register and Claim Ownership